These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1531789)

  • 1. The rate of increase in hematocrit, humoral vasoactive substances and blood pressure changes in hemodialysis patients treated with recombinant human erythropoietin or blood transfusion.
    Ono K; Hisasue Y
    Clin Nephrol; 1992 Jan; 37(1):23-7. PubMed ID: 1531789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
    Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between vasoactive substances and changes in blood pressure during hemodialysis].
    Takahashi M
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):549-57. PubMed ID: 7474507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients.
    Heintz B; Reiners K; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H; Sieberth HG
    Clin Nephrol; 1993 Apr; 39(4):198-204. PubMed ID: 8491049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of erythropoietin treatment on blood pressure and intracellular cation concentrations in maintenance hemodialysis patients.
    Okura Y; Oshima T; Yasunobu Y; Amano K; Mori M; Shinozaki K; Kajiyama G
    Hypertens Res; 1996 Jun; 19(2):91-5. PubMed ID: 10968201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute effects of human recombinant erythropoietin on cardiovascular dynamics and vasoactive substances].
    Suga M; Kurihara S; Iino Y; Terashi A
    Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):634-9. PubMed ID: 9014484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of anemia in patients after long term hemodialysis with human recombinant erythropoietin].
    Boratyńska M; Mazanowska O; Szewczyk Z
    Pol Merkur Lekarski; 1996 Nov; 1(5):329-31. PubMed ID: 9273209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Martins Prata M; Teixeira de Sousa F; Barbas J; Vinhaś J; Marques da Costa A
    Rev Port Cardiol; 1990 Feb; 9(2):119-23. PubMed ID: 2346662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of erythropoietin treatment on plasma renin activity, aldosterone, vasopressin and atrial natriuretic peptide in haemodialyzed patients.
    Kokot F; Wiecek A; Grzeszczak W; Klin M
    Miner Electrolyte Metab; 1990; 16(1):25-9. PubMed ID: 2139159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters].
    Köhler M; Mörsdorf S; Jung F; Braun B; Waldhausen P; Pindur G; Weber U; Bosslet R; Bambauer R; Jutzler GA
    Beitr Infusionsther; 1990; 26():89-95. PubMed ID: 1703909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete correction of renal anemia by recombinant human erythropoietin.
    Ludat K; Paulitschke M; Riedel E; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S42-9. PubMed ID: 10746805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin].
    Burak W; Grzeszczak W; Trelewicz P; Zukowska-Szczechowska E
    Przegl Lek; 1996; 53(2):54-7. PubMed ID: 8754321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients.
    Lebel M; Kingma I; Grose JH; Langlois S
    Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationships among the renin-angiotensin system, sympathetic nervous system and atrial natriuretic peptide in end-stage renal failure.
    Nakajima S; Suzuki H; Kageyama Y; Ogata Y; Saruta T
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):305-11. PubMed ID: 2141372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M; Umezu M; Nagano M; Tagawa H
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.